Clinical Trials Logo

Healthy Males clinical trials

View clinical trials related to Healthy Males.

Filter by:

NCT ID: NCT01032616 Completed - Healthy Males Clinical Trials

Uptake and Utilization of Amino Acids by Splanchnic Bed

Start date: December 2009
Phase: Phase 1
Study type: Interventional

Splanchnic uptake and metabolism contributes significantly to the differences in flux seen between the intravenous and intragastric ingestion of certain indispensable amino acids. This is the third in a series of studies designed to increase the investigators knowledge of the metabolism of two indispensable amino acids, threonine and lysine, by the splanchnic bed. In the initial two studies the investigators established the neonatal parenteral requirement of threonine and lysine. In the current study, the investigators will be examining the differences in uptake and metabolism of threonine and lysine across the splanchnic bed.

NCT ID: NCT00902512 Completed - Healthy Males Clinical Trials

Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations

Start date: April 2009
Phase: Phase 4
Study type: Interventional

the pharmacokinetics of sildenafil following single doses of sildenafil CT administered with and without water is similar relative to the conventional oral tablet of sildenafil administered with water.

NCT ID: NCT00842751 Completed - Healthy Males Clinical Trials

Oral T7 Oral Testosterone in Man

Oral T7
Start date: July 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test how the body absorbs and processes new forms of oral testosterone. Information gained during the study may help develop better forms of testosterone therapy in the future.

NCT ID: NCT00839319 Completed - Healthy Males Clinical Trials

HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone

HOP-3
Start date: March 2009
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this investigational study is to determine how much male hormone, testosterone, is necessary to maintain sperm production in the testis. This knowledge will be used to help in the development of a safe male hormonal contraception.

NCT ID: NCT00782392 Completed - Healthy Males Clinical Trials

Bioavailability and Dosing of a Monosaccharide Supplement in Adults

Start date: January 2007
Phase: N/A
Study type: Observational

We are developing an oral supplement of carbohydrates to be added to infant formulas in order to improve brain development, immune function, and overall health of infants and children. After a careful review of what is known about these sugars, there is very little information regarding their use in infants and children, although there is some information in adults and animals. Many of these sugars have been used in a glyco-nutritional supplement in adults and children, with minimal or no reported side effects. We are developing a custom blend of important individual sugars, and need information regarding their dosing and blood concentrations following oral intake of the carbohydrate supplement. Timed blood samples following the carbohydrate supplement will provide us with a better understanding of the most effective dose and the metabolism of these sugars in adults. This will give us the preliminary information we need for developing an oral supplement of special sugars that can be added to infant formulas to help improve brain development and immune function in infants and children.

NCT ID: NCT00777543 Completed - Healthy Males Clinical Trials

Increasing Ferulic Acid Bioavailability in Bran

Start date: November 2008
Phase: N/A
Study type: Interventional

The aim of the present study is to investigate the effect of pretreatment of bran on improving the bioavailability of ferulic acid in wholegrain breads containing bran. As secondary endpoints we will investigate the changes in plasmatic antioxidant capacity, anti-inflammatory effects, colonic metabolites from ferulic acid and short chain fatty acids (SCFA).

NCT ID: NCT00475371 Completed - Clinical trials for Diabetes Mellitus, Type 2

A First in Human, Single Dose, Safety and Tolerability Study of MKC253 Inhalation Powder in Healthy Adult Males

Start date: April 2007
Phase: Phase 1
Study type: Interventional

26 subjects will be enrolled into 5 different dose groups. The trial will consist of a screening, a dosing and a follow-up visit. Dosing at visit 2, of MKC253 Inhalation Powder, Glucagon-Like Peptide-1 (GLP-1) will be given at 5 dose levels.